Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and ...

The northward move in Marksans Pharma came after the company's wholly-owned subsidiary, Relonchem, received Marketing ...

In the complex pharmaceutical market, achieving high levels of brand memorability directly influences patient choices and adherence, making it a critical focus for marketing strategies.

Marksans Pharma advanced 2.61% to Rs 208.15 after the company's wholly owned subsidiary in the UK, Relonchem, has received marketing authorization for Baclofen Tablets from the UK Medicines and ...

Brand.com’s are connecting HCPs to information, with fewer hoops to jump through, courtesy of new digital tools promising to ...

Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to tighten its belt in anticipation of a generic heart med incursion later thi | ...

Fresh off a pivot from commercial pharma business to preclinical biotech, Aadi Bioscience has rebranded to better match its ...

The 39th PM Society Awards, supported by headline sponsor Avalere Health, were held on 14 March 2025 at the JW Marriott ...

The rise of artificial intelligence (AI), digitalisation, wider adoption of tools for marketing automation, and numerous other technologies have significantly reshaped the world of pharma for the ...

Today, any pharma marketing strategy has to take into account the perspective of multiple stakeholders, such as doctors, regulators, payers and the patient. Here, we speak with Dr Simone Seiter ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...